The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling
- 14 August 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Structural & Molecular Biology
- Vol. 18 (9), 971-976
- https://doi.org/10.1038/nsmb.2099
Abstract
The pseudokinase JH2 domain of JAK2 is a negative regulator of JAK2 activity, but the mechanism for this is unclear. Now it is shown that JH2 is actually an active kinase that phosphorylates negative regulatory sites on JAK2, thus inhibiting JAK2 signaling. Human JAK2 tyrosine kinase mediates signaling through numerous cytokine receptors. The JAK2 JH2 domain functions as a negative regulator and is presumed to be a catalytically inactive pseudokinase, but the mechanism(s) for its inhibition of JAK2 remains unknown. Mutations in JH2 lead to increased JAK2 activity, contributing to myeloproliferative neoplasms (MPNs). Here we show that JH2 is a dual-specificity protein kinase that phosphorylates two negative regulatory sites in JAK2: Ser523 and Tyr570. Inactivation of JH2 catalytic activity increased JAK2 basal activity and downstream signaling. Notably, different MPN mutations abrogated JH2 activity in cells, and in MPN (V617F) patient cells phosphorylation of Tyr570 was reduced, suggesting that loss of JH2 activity contributes to the pathogenesis of MPNs. These results identify the catalytic activity of JH2 as a previously unrecognized mechanism to control basal activity and signaling of JAK2.This publication has 40 references indexed in Scilit:
- Pseudokinases-remnants of evolution or key allosteric regulators?Current Opinion in Structural Biology, 2010
- ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylationProceedings of the National Academy of Sciences of the United States of America, 2010
- Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3Proceedings of the National Academy of Sciences of the United States of America, 2009
- Structure of the LKB1-STRAD-MO25 Complex Reveals an Allosteric Mechanism of Kinase ActivationScience, 2009
- Structure and functional characterization of the atypical human kinase haspinProceedings of the National Academy of Sciences of the United States of America, 2009
- Structure of the Pseudokinase VRK3 Reveals a Degraded Catalytic Site, a Highly Conserved Kinase Fold, and a Putative Regulatory Binding SiteStructure, 2009
- CASK Functions as a Mg2+-Independent Neurexin KinaseCell, 2008
- JAK2Exon 12 Mutations in Polycythemia Vera and Idiopathic ErythrocytosisThe New England Journal of Medicine, 2007
- In-gel digestion for mass spectrometric characterization of proteins and proteomesNature Protocols, 2006
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005